Cybin (HELP) Current Assets (2021 - 2025)
Cybin (HELP) reported Current Assets of $115.7 million for Q1 2025, down 28.68% on a YoY basis from $162.2 million in Q1 2024, and down 3.64% quarter-over-quarter from $120.0 million in Q4 2024.
Cybin (HELP) Current Assets (2021 - 2025) Analysis & Trends
Cybin has reported Current Assets for 5 years, with the latest figure at $115.7 million in Q1 2025.
- For the quarter ending Q1 2025, Current Assets fell 28.68% year-over-year to $115.7 million; the trailing twelve-month figure through Mar 2025 stood at $115.7 million (down 28.68% YoY), and the FY2025 full-year result was $119.4 million, down 26.38% from the prior year.
- Current Assets for Q1 2025 stood at $115.7 million, down from $120.0 million in the prior quarter.
- The five-year high for Current Assets was $162.2 million in Q1 2024, with the low at $19.0 million in Q2 2023.
- Historically, Current Assets has averaged $70.1 million across 5 years, with a median of $52.5 million in 2021.
- Annual changes were most pronounced in 2022 — Current Assets slumped 59.57% — and 2024, when it soared 674.47%.
- Cybin's Current Assets stood at $54.9 million in 2021, then tumbled by 59.57% to $22.2 million in 2022, then jumped by 61.35% to $35.8 million in 2023, then soared by 235.44% to $120.0 million in 2024, then slipped by 3.64% to $115.7 million in 2025.
- The last three Current Assets figures came in at $115.7 million (Q1 2025), $120.0 million (Q4 2024), and $131.0 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 3.59 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 600.85 Mn |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 115.67 Mn |
| Dec 31, 2024 | 120.04 Mn |
| Sep 30, 2024 | 131.02 Mn |
| Jun 30, 2024 | 146.79 Mn |
| Mar 31, 2024 | 162.18 Mn |
| Dec 31, 2023 | 35.79 Mn |
| Sep 30, 2023 | 19.95 Mn |
| Jun 30, 2023 | 18.95 Mn |
| Feb 28, 2023 | 31.90 Mn |
| Dec 31, 2022 | 22.18 Mn |
| Sep 30, 2022 | 29.36 Mn |
| Dec 31, 2021 | 54.85 Mn |
| Sep 30, 2021 | 63.12 Mn |
| Jun 30, 2021 | 46.83 Mn |
| Mar 31, 2021 | 52.53 Mn |